Streetbeat News

Products Services

KOPN

Kopin Corporation has received a second production order for its CR3 wearable surgical monitor from HMDmd, Inc. The CR3 is a high-performance head-mounted display compatible with various surgical systems.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:37 pm

GILD

Gilead Sciences announced positive interim results from a second Phase 3 trial of its drug Lenacapavir, which showed a 96% reduction in HIV infections with twice-yearly administration.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:36 pm

TEM

Tempus AI, Inc. (NASDAQ:TEM) has launched the beta version of 'olivia', an AI-enabled personal health concierge app. The app aims to help patients manage their health data more effectively by aggregating information, tracking symptoms, and preparing for medical appointments.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:36 pm

AMPG

AmpliTech Group's AGTGSS division has received a $50,000 initial order from the University of Edinburgh for midband 5G radio networks. This order marks a significant step for AmpliTech in expanding its presence in the 5G market.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:34 pm

EBS

Emergent BioSolutions Inc. (NYSE:EBS) has been awarded a $41.9 million contract modification by BARDA for the continued development and procurement of Ebanga, a treatment for Ebola. This funding will support drug substance engineering, process validation, and commercial readiness.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:34 pm

JNJ

Johnson & Johnson (JNJ) announced results from a Phase 2 study on Rybrevant for lung cancer and recently agreed to acquire V-Wave for $600 million. The company offers a 3.01% annual dividend yield, translating to $1.24 per share quarterly. To earn $500 monthly from dividends, an investment of approximately $199,432 is needed. JNJ shares fell 1.5% to $164.82.

Portfolio Pulse from Avi Kapoor

September 12, 2024 | 12:33 pm

TCBP

TC BioPharm (NASDAQ:TCBP) announced that the first patient has completed the full dose regimen in the ACHIEVE Phase 2b trial with no adverse events related to TCB008. This milestone in the UK trial involves patients receiving up to four doses of TCB008, with the first patient receiving approximately one billion cells.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:33 pm

TPET

Trio Petroleum has successfully initiated oil production from its first well at the Asphalt Ridge Project in Utah. The company is using a downhole heater to reduce bitumen viscosity, facilitating the pumping process to the surface.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:33 pm

RDEI

RDE Inc. has announced significant milestones for its CardCash B2B platform in 2024, including a 10% monthly customer growth, over $3 million in program savings, and 1,000 additional orders per month. The platform will also expand its brand diversity to over 500 retail brands.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:33 pm

FLUX

Flux Power has announced a strategic partnership with a leading forklift OEM to launch a new private label battery program. Their S-Series products now include UL Type EE certification, enhancing safety, performance, and environmental sustainability.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 12:31 pm